Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1165]

Culture, Community and Communication in Advanced Disease in India

Dr Dwai Banerjee - Massachusetts Institute of Technology, Boston, USA

Culture, Community and Communication in Advanced Disease in India ( Dr Dwai Banerjee - Massachusetts Institute of Technology, Boston, USA )

Current state of prostate cancer in Antigua and Barbuda

Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda

Current state of prostate cancer in Antigua and Barbuda ( Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda )

Part 1: When to test

PARP inhibition in the treatment of prostate cancer

Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )

Part 2: Who to test

PARP inhibition in the treatment of prostate cancer

Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )

The role of testing in prostate cancer treatment

Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki

The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )

Prostate cancer screening using prostate-specific antigen, a multiplex blood...

Prof Martin Eklund - Karolinska Institutet, Solna, Sweden

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )

Clinically sufficient vitamin D levels at breast cancer diagnosis and survival...

Prof Song Yao - Roswell Park Comprehensive Cancer Center, Buffalo, USA

Clinically sufficient vitamin D levels at breast cancer diagnosis and survival outcomes ( Prof Song Yao - Roswell Park Comprehensive Cancer Center, Buffalo, USA )

CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC

Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA

CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC ( Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA )

LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and...

Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain

LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor ( Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain )

OncoAlert and ecancer ASCO roundup - Day 3

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 3 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

OncoAlert and ecancer ASCO roundup - Day 2

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 2 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

OncoAlert and ecancer ASCO roundup - Day 1

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 1 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

More from ecancer